Compare Agilent Technologies Inc (A) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Nvidia Corp — how do they compare? Agilent Technologies Inc trades at $146.93 (market cap $41.42B), while Nvidia Corp trades at $218.17 (market cap $5.27T). The key difference: Nvidia Corp is far larger — about 127.2× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays the higher dividend (0.69%). Which is the better fit depends on your goals.
| A | NVDA | |
|---|---|---|
Market Cap | $41.42B | $5.27T |
Sector | Health | Technology |
52-Week High | $158.93 | $235.75 |
52-Week Low | $110.24 | $165.17 |
Enterprise Value | $43.61B | $5.25T |
Dividend Yield | 0.69% | 0.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $146.93, up 1.49% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 earnings beat expectations with EPS of $1.62 versus $1.49 estimated, and the company raised its annual profit forecast amid improving demand for lab tools. The stock exhibits solid fundamentals, including a 19.53% net income margin and 20.97% ROE, though valuation multiples like a P/E of 28.23 are elevated relative to historical norms.
The outlook remains positive given earnings momentum and new product launches, but risks include competitive pressures and reliance on research spending. With 80% of analysts rating it a Buy and a consensus price target of $180.17, the stock offers upside potential, though investors should weigh high valuation against growth sustainability.
NVIDIA (NVDA) trades at $218.4, down 2.41% on the day, amid a broader tech sell-off. The stock exhibits a bullish technical signal with strong fundamentals, including a 55.84% net income margin and consistent earnings beats. Revenue surged to $130.5B in 2025, with robust cash flow from operations of $64.09B. Analyst consensus remains strongly bullish with a $342.09 price target, though recent news highlights concerns over growth sustainability and market rotation.
Outlook: NVDA's leadership in AI chips and projected revenue growth to $303.0B in 2026 present significant upside, but risks include peak AI spending fears and increased competition. The stock's high valuations (P/E 27.61) require continued execution to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
